Trial :

A Study for Parkinson's Disease

Age :

18 - 65 years

Trial length :

13 nights

Info :

1 follow up visit and phone consultation

Scientia is conducting a study for a potential treatment of Parkinson's' disease.

This study involves an oral capsule but Parkinson’s Disease, a progressive neurodegenerative disorder affecting 1-2% of individuals over 65 years of age, with the prevalence expected to increase due to global aging.

For this trial we need the help of healthy males and females  aged from 18-65 (inclusive).

This requires an in-house stay of 13 nights, with 1 follow up visit and an additional phone consultation.

Healthy volunteers will be reimbursed for their time.

To be eligible you must:

  • Be a healthy male or female
  • Must comply with contraception requirements
  • Aged 18 to 65 years
  • Non-smokers
  • No history of drug or alcohol abuse

Participants will be asked to undergo a single spinal tap during the admission to collect Cerebrospinal Fluid (CSF).

This will be performed within the unit by an experienced anaesthetist.

If you meet the criteria for this study and would like more information, register below, email our recruitment team (recruitment@scientiaclinicalresearch.com.au) or call 1800 727 874

Apply Now